Fig. 1
Fig. 2
Fig. 3
Fig. 4
Mean egg count±standard deviation for the three species of wild ruminants – European mouflon (Ovis musimon), roe deer (Capreolus capreolus) and fallow deer (Dama dama) during the experimental infection with resistant (MHco4) strain of H_ contortus_
| EPG | EPG | EPG | EPG | EPG | |
|---|---|---|---|---|---|
| D16 | D37 | D58 | D77 | D99 | |
| Mouflon n=3 | 0.0 ± 0.0 | 12 250 ± 105.48 | 25 400 ± 432.00 | 19 850 ± 550.00 | 0 ± 0 |
| Fallow deer n=3 | 100 ± 60.28 | 150 ± 55.20 | 150 ± 55.54 | 0 ± 0 | 0 ± 0 |
| Roe deer n=3 | 0.0 ± 0.0 | 50 ± 47.25 | 150 ± 57.35 | 0 ± 0 | 0 ± 0 |
Leucogram results - Agranulocytic line in mouflons (Ovis musimon), roe deer (Capreolus capreolus) and fallow deer (Dama dama) during the experimental infection with resistant (MHco4) strain of H_ contortus (%)_
| Day of blood collection | Mouflon (Ovis musimon) | Roe deer (Dama dama) | Fallow deer (Capreolus capreolus) | |
|---|---|---|---|---|
| Average ± SD | ||||
| Lymphocytes (%) | D0 - infection | 61.53 ± 1.26 | 39.80 ± 0.53 | 2.06 ± 1.06 |
| D16 | 71.90 ± 4.30 | 53.33 ± 2.51 | 2.56 ± 1.14 | |
| D37 | 42.70 ± 2.65 | 54.03 ± 2.08 | 3.70 ± 1.10 | |
| D58 | 45.33 ± 2.35 | 54.36 ± 0.73 | 2.70 ± 0.74 | |
| D77 + treatment | 40.33 ± 4.02 | 56.63 ± 6.50 | 1.43 ± 0.49 | |
| D99 - D21post treatment | 50.53 ± 2.60 | 50.43 ± 0.75 | 2.33 ± 1.13 | |
| Monocytes (%) | D0 - infection | 1.60 ± 0.50 | 6.63 ± 0.89 | 0±0 |
| D16 | 3.57 ± 1.30 | 6.00 ± 0.81 | 0±0 | |
| D37 | 3.47 ± 0.44 | 5.70 ± 0.53 | 0±0 | |
| D58 | 2.00 ± 0.81 | 4.06 ± 0.17 | 0±0 | |
| D77 + treatment | 2.66 ± 1.24 | 4.03 ± 0.12 | 0±0 | |
| D99 - D21post treatment | 2.77 ± 0.20 | 4.06 ± 0.16 | 0±0 | |
Leucogram results - granulocytic line in three species of wild ruminants infected with resistant (MHco4) strain of H_ contortus (%)_
| Day of blood collection | Mouflon | Roe deer | Fallow deer | |
|---|---|---|---|---|
| (Ovis musimon) | (Dama dama) | (Capreolus capreolus) | ||
| Average ± SD | ||||
| Neutrophilic granulocytes (%) | D0 - infection | 33.80 ± 1.51 | 45.60 ± 0.63 | 93.20 ± 0.35 |
| D16 | 21.80 ± 5.58 | 34.13 ± 1.59 | 85.33 ± 1.11 | |
| D37 | 51.17 ± 2.01 | 33.20 ± 2.46 | 83.90 ± 0.53 | |
| D58 | 50.00 ± 2.16 | 36.60 ± 0.88 | 86.10 ± 0.77 | |
| D77 + treatment | 54.67 ± 5.43 | 32.46 ± 6.64 | 88.20 ± 1.15 | |
| D99 - D21 post treatment | 41.00 ± 4.32 | 39.20 ± 0.65 | 87.13 ± 0.12 | |
| Eosinophilic granulocytes (%) | D0 - infection | 1.80 ± 0.43 | 3.16 ± 0.12 | 3.36 ± 1.23 |
| D16 | 2.10 ± 0.16 | 3.13 ± 0.26 | 7.26 ± 0.60 | |
| D37 | 1.67 ± 0.47 | 2.46 ± 0.36 | 8.30 ± 0.43 | |
| D58 | 2.33 ± 0.47 | 2.33 ± 0.47 | 8.63 ± 0.52 | |
| D77 + treatment | 2.00 ± 0.0 | 1.97 ± 0.04 | 9.00 ± 1.48 | |
| D99 - D21 post treatment | 3.24 ± 1.43 | 1.96 ± 0.04 | 8.36 ± 0.57 | |
| Basophilic granulocytes (%) | D0 - infection | 0.93 ± 0.73 | 4.80 ± 0.24 | 1.36 ± 0.33 |
| D16 | 0.63 ± 0.44 | 3.40 ± 0.29 | 4.63 ± 0.52 | |
| D37 | 0.33 ± 0.47 | 4.60 ± 0.08 | 4.10 ± 1.42 | |
| D58 | 0.33 ± 0.47 | 2.63 ± 0.44 | 2.56 ± 0.70 | |
| D77 + treatment | 0.67 ± 0.47 | 4.90 ± 0.08 | 1.36 ± 0.46 | |
| D99 - D21 post treatment | 2.10 ± 0.78 | 4.33 ± 0.26 | 2.16 ± 0.52 | |